SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,590.11 -64.49
( -0.08%)

Global Indices

Nasdaq

51,626.09 -1,142.23
(-2.16%)

Dow Jones

7,338.46 -111.32
(-1.49%)

Hang Seng

61,006.88 -1,358.04
(-2.18%)

Nikkei 225

10,896.96 25.94
(0.24%)

Forex

USD-INR

95.71 -0.26
(-0.27%)

EUR-INR

108.89 -0.40
(-0.37%)

GBP-INR

127.22 -0.62
(-0.49%)

JPY-INR

0.58 0.00
(-0.38%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

45.08

42445.63

EPS(TTM)

Face Value()

Div & Yield %

75.36

0.83

Date	Headline
20-Jul-2026	Ajanta Pharma to table results
13-Jul-2026	Ajanta Pharma Ltd gains for third consecutive session
15-Jun-2026	Ajanta Pharma to conduct AGM
05-Jun-2026	Ajanta Pharma Ltd gains for third straight session
13-May-2026	Ajanta Pharma Ltd spurts 1.08%, rises for third straight session
06-May-2026	Ajanta Pharma rises after Q4 PAT climbs 18% YoY
06-May-2026	Nifty trades above 24,150 mark; auto shares rev up for 3rd day
06-May-2026	Volumes soar at Tejas Networks Ltd counter
05-May-2026	Ajanta Pharma consolidated net profit rises 18.40% in the March 2026 quarter
22-Apr-2026	Ajanta Pharma's Paithan unit concludes USFDA inspection

<< < 1 2 > >>

77,590.11 -64.49 ( -0.08%)

51,626.09 -1,142.23 (-2.16%)

7,338.46 -111.32 (-1.49%)

61,006.88 -1,358.04 (-2.18%)

10,896.96 25.94 (0.24%)

95.71 -0.26 (-0.27%)

108.89 -0.40 (-0.37%)

127.22 -0.62 (-0.49%)

0.58 0.00 (-0.38%)